Of note, the CHOP-mediated suppression of steatosis and the tumor progression driven by IRE1α in liver steatosis models contradict its positive upregulation of lipogenesis in triple-negative breast cancer and pro-tumor proliferation/chemotherapy resistance in NSCLC discussed above. This evidence concerns the gene ERN1 and triple-negative breast carcinoma.